The Glutaminase-1 Inhibitor 968 Enhances Dihydroartemisinin-Mediated Antitumor Efficacy in Hepatocellular Carcinoma Cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Glutaminase-1 Inhibitor 968 Enhances Dihydroartemisinin-Mediated Antitumor Efficacy in Hepatocellular Carcinoma Cells
Authors
Keywords
Hepatocellular carcinoma, Cytotoxicity, Endothelial cells, MTT assay, Cancer treatment, Cell staining, Glutamine, Reactive oxygen species
Journal
PLoS One
Volume 11, Issue 11, Pages e0166423
Publisher
Public Library of Science (PLoS)
Online
2016-11-12
DOI
10.1371/journal.pone.0166423
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
- (2015) Yan Xiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
- (2015) Decai Yu et al. Oncotarget
- Glutaminase: A Hot Spot For Regulation Of Cancer Cell Metabolism?
- (2015) Oncotarget
- Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations
- (2013) Ashkan Emadi et al. EXPERIMENTAL HEMATOLOGY
- Multifunctional antitumor molecule 5′-triphosphate siRNA combining glutaminase silencing and RIG-I activation
- (2013) Gang Meng et al. INTERNATIONAL JOURNAL OF CANCER
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- Anti-cancer activity of DHA on gastric cancer—an in vitro and in vivo study
- (2013) Haijun Sun et al. TUMOR BIOLOGY
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
- (2012) Anne Le et al. Cell Metabolism
- Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism
- (2012) K. Thangavelu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway
- (2011) Shuang-Jia Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Metabolism: Is Glutamine Sweeter than Glucose?
- (2010) Weiqin Lu et al. CANCER CELL
- Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
- (2010) Jian-Bin Wang et al. CANCER CELL
- Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo
- (2010) Shuang-Jia Wang et al. CANCER LETTERS
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
- (2010) M. J. Seltzer et al. CANCER RESEARCH
- The JNK inhibitor SP600125 enhances dihydroartemisinin-induced apoptosis by accelerating Bax translocation into mitochondria in human lung adenocarcinoma cells
- (2010) Ying-Ying Lu et al. FEBS LETTERS
- The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells
- (2010) Jin-Jian Lu et al. INVESTIGATIONAL NEW DRUGS
- Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells
- (2010) Tan Weifeng et al. PHYTOMEDICINE
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- Therapeutic strategies by modulating oxygen stress in cancer and inflammation
- (2009) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB
- (2009) Hua Chen et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
- (2009) Ping Gao et al. NATURE
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Redox Regulation of Cell Survival
- (2008) Dunyaporn Trachootham et al. ANTIOXIDANTS & REDOX SIGNALING
- Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
- (2008) Tao Chen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started